PT Bank Mandiri (Persero) Tbk (BMRI) has officially concluded its strategic withdrawal from PT Asuransi Jiwa Inhealth Indonesia, marking a significant shift in the state-owned enterprise’s portfolio management. In a formal disclosure submitted to the Indonesia Stock Exchange (IDX) on October 28, 2026, Bank Mandiri confirmed the execution of a Conditional Share Purchase Agreement (CSPA) involving the divestment of its remaining 20% stake in Inhealth to PT Asuransi Jiwa IFG (IFG Life). The transaction, valued at IDR 570 billion, was finalized on October 26, 2026, effectively transferring full ownership of Inhealth to the IFG Life ecosystem.
This divestment represents a calculated step in the broader national strategy to consolidate state-owned insurance assets. By offloading its remaining 200,000 shares, Bank Mandiri has successfully exited the health insurance entity, allowing the company to focus on its core banking operations and its remaining insurance subsidiary, AXA Mandiri Financial Services.
Chronology of Inhealth Ownership Transformation
The path toward full IFG Life ownership of Inhealth has been a multi-year process aimed at rationalizing the government’s insurance holdings. Historically, Inhealth operated under a fragmented ownership structure. Before the restructuring efforts began in earnest, Bank Mandiri held a dominant 80% stake, with the remaining 20% split between PT Kimia Farma Tbk and IFG Life.
The transition began in earnest on June 26, 2024, when a significant realignment occurred. During this period, Inhealth was integrated into the IFG Holding structure, positioning it as a subsidiary of IFG Life. This shift was part of a larger initiative to streamline the insurance sector under the supervision of the Danantara Asset Management (DAM) and the IFG holding company. With the latest transaction finalized in October 2026, the ownership landscape has been simplified: IFG Life now holds 100% of the equity in Inhealth, marking the end of Bank Mandiri’s involvement as a shareholder.
Strategic Rationale: Streamlining State Assets
Management at Bank Mandiri emphasized that this divestment is not merely a financial transaction but a strategic alignment with national policy. The move is designed to support the "streamlining of life insurance" initiatives mandated by the government. The goal is to strengthen the domestic insurance industry, enabling it to compete more effectively with international insurance giants that operate within the Indonesian market.
By consolidating Inhealth under the IFG umbrella, the government aims to create a more cohesive and efficient insurance entity. The synergy between IFG Life and Inhealth is expected to reduce operational redundancies and improve service delivery for policyholders. Furthermore, the involvement of Danantara Asset Management underscores the importance of this consolidation, as the government seeks to optimize the performance of its financial sector assets.
Bank Mandiri’s management noted in their filing that because the divestment involves an affiliated party—IFG Life—the transaction is classified as an "Affiliated Transaction" under the Financial Services Authority (OJK) Regulation No. 42/2020. However, because the financial metrics of the transaction—including the total asset value, net profit, and business revenue—fall significantly below the 20% threshold of Bank Mandiri’s equity, it is not categorized as a "Material Transaction." Consequently, the bank was not required to seek approval from the General Meeting of Shareholders (RUPS) to proceed with the sale.
Contextualizing Bank Mandiri’s Insurance Portfolio
While the divestment of Inhealth is a notable exit, it does not signal a retreat from the insurance sector for Bank Mandiri. The bank continues to maintain a robust footprint in the financial services industry. Its most prominent insurance vehicle remains AXA Mandiri Financial Services, where Bank Mandiri holds a 51% controlling stake.
Bank Mandiri’s investment strategy remains focused on high-growth areas within the financial ecosystem. Beyond the insurance sector, the bank’s portfolio includes a diverse range of subsidiaries that provide comprehensive financial solutions:
- Mandiri Taspen: Specializing in pension and micro-financing.
- Mandiri Sekuritas: A leading player in the Indonesian capital markets.
- Mandiri Tunas Finance & Mandiri Utama Finance: Key players in the automotive and consumer financing sectors.
- Mandiri Capital: The bank’s venture capital arm, focused on fintech innovation.
- Bank Mandiri Europe Limited: Facilitating international trade and global banking services.
- Mandiri Remittance: Handling cross-border financial transactions.
The exit from Inhealth allows the bank to reallocate capital and management focus toward these core subsidiaries, further optimizing its return on assets.
Financial and Industry Implications
The valuation of IDR 570 billion for the 20% stake provides a clear benchmark for the current market value of Inhealth. For the insurance industry in Indonesia, this move is a strong indicator of the trend toward consolidation. The government has long signaled its intent to reduce the number of state-owned entities involved in similar business lines to minimize competition among state-controlled firms and maximize market impact.
Analysts observe that the consolidation of Inhealth into IFG Life creates a more formidable player in the health insurance market. By pooling resources, expertise, and infrastructure, the merged entity is better positioned to leverage economies of scale. This is particularly crucial as Indonesia continues to expand its universal health coverage programs and as the private insurance market grows in response to an aging population and rising healthcare costs.
Furthermore, this divestment serves as a proof-of-concept for the role of Danantara Asset Management in managing state-owned financial institutions. The successful transition of ownership without disrupting the services provided to Inhealth’s policyholders suggests that the regulatory and operational frameworks established by the Indonesian government are maturing.
The Role of Danantara Asset Management (DAM)
The emergence of Danantara Asset Management as a central player in this transition is noteworthy. As a newly prominent entity in the state-owned investment landscape, DAM’s involvement signals a shift toward more professionalized asset management. The directive to "synergize between affiliated parties" is a hallmark of this new governance structure.
By aligning the interests of IFG Life and the broader insurance holding company, the government expects to achieve better risk management and a more stable financial performance across the insurance sector. This consolidation is also expected to improve the capital adequacy ratios of the involved firms, ensuring that they remain resilient in the face of global economic volatility.
Future Outlook
For Bank Mandiri, the divestment of Inhealth is a closed chapter, but it highlights the bank’s ongoing commitment to portfolio optimization. With the Indonesian economy projected to maintain a steady growth trajectory, the focus for the "golden ribbon" bank will likely remain on digital transformation and expanding its core banking services.
As the market absorbs the news of the IDR 570 billion transaction, attention will turn to how IFG Life integrates Inhealth’s operations into its long-term strategy. The success of this consolidation will be measured by its ability to offer competitive premiums, expand market penetration in the health insurance segment, and contribute positively to the overall stability of the Indonesian financial system.
For stakeholders and investors, the transaction is viewed as a rational step that reduces complexity within the Bank Mandiri corporate structure. While Inhealth was a legacy investment that served the bank well, its transition into the dedicated insurance holding company is widely regarded as a logical progression for the Indonesian state-owned financial sector.
In conclusion, the sale of Inhealth to IFG Life is a milestone in the institutional restructuring of Indonesia’s insurance market. It reflects a broader shift toward specialization, where banking institutions prioritize their core financial functions while insurance entities are consolidated under centralized management to ensure long-term viability and competitive strength on the global stage. Bank Mandiri’s exit is a strategic move that balances its current portfolio, reinforces its relationship with its existing subsidiaries, and supports the government’s vision for a more efficient state-owned enterprise landscape.
